Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
217 hedge funds and large institutions have $1.48B invested in Immunogen Inc in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 71 reducing their positions, and 26 closing their positions.
99% more call options, than puts
Call options by funds: $7.1M | Put options by funds: $3.56M
32% more capital invested
Capital invested by funds: $1.12B → $1.48B (+$359M)
27% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 26
3% more funds holding
Funds holding: 211 → 217 (+6)
1% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 71
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$53.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$30.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.5M |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$15.1M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
+$15.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.2M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$23M |
| 3 |
Renaissance Technologies
New York
|
-$19.4M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$12.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12.4M |
IMGN Hedge Fund Activity: Q1 2021 in Review
217 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2021, worth a combined $1.48B — up 32% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new IMGN positions and 26 closed out — a net gain of 7 holders — while 72 added to existing stakes and 71 trimmed.
The largest buyer was OrbiMed, adding an estimated $53.7M. The largest seller was Wellington Management Group, cutting an estimated $25.2M.
- 217 institutional investors held Immunogen Inc (IMGN) as of Q1 2021, up from 211 in Q4 2020.
- Funds reported $1.48B of Immunogen Inc stock for Q1 2021, up 32% quarter-over-quarter.
- 33 funds opened new Immunogen Inc positions in Q1 2021 and 26 closed out, a net change of +7 holders.
- The largest Immunogen Inc buyer in Q1 2021 was OrbiMed, an estimated $53.7M added.
- The largest Immunogen Inc seller in Q1 2021 was Wellington Management Group, an estimated $25.2M sold.
Based on aggregated 13F filings for Q1 2021.